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ABSTRACT OF THESIS 
 
 
 
 
HUMAN RIBOSOMAL RNA GENE CLUSTERS ARE RECOMBINATIONAL 
HOTSPOTS IN CANCER 
 
 
 The gene that produces the precursor RNA transcript to the three largest 
ribosomal RNA molecules (rDNA) is present in multiple copies and organized into 
gene clusters. They represent 0.5% of the diploid human genome but are critical 
for cellular viability. The individual genes possess very high levels of sequence 
identity and are present in high local concentration, making them ideal substrates 
for genomic rearrangement driven by dysregulated homologous recombination. 
Our laboratory has developed a sensitive physical assay capable of detecting 
recombination-mediated genomic restructuring in the rDNA by monitoring 
changes in lengths of the individual clusters. In order to determine whether 
dysregulated recombination is a potential driving force of genomic instability in 
human cancer, adult patients with either lung or colorectal cancer, and pediatric 
patients with leukemia were prospectively recruited and assayed. Over half of the 
adult solid tumors show detectable rDNA rearrangements relative to either 
surrounding non-tumor tissue or normal peripheral blood. In contrast, there is a 
greatly reduced frequency of alteration in pediatric leukemia. This finding makes 
rDNA restructuring one of the most common chromosomal alterations in adult 
solid tumors, illustrates the dynamic plasticity of the human genome, and may 
have prognostic or predictive value in disease progression. 
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CHAPTER ONE 
 
Introduction 
 
The human ribosomal RNA gene clusters (rDNA clusters) produce 45S precursor 
transcripts subsequently processed to make three of the four structural RNA 
components of the ribosome, and are critically required for protein synthesis and 
cellular viability. The rDNA clusters, which comprise collectively hundreds of 
gene copies, are located on the short arms of the five human acrocentric 
chromosome pairs (13p12, 14p12, 15p12, 21p12, 22p12: OMIM 180450– 
180454) and are generally organized with individual genes in head-to-tail 
tandemly repeated arrays (1). The individual genes are each 43 kb in length (2), 
with near perfect sequence conservation. Extremely high sequence similarity 
combined with the length of the individual repeats makes both shotgun-based 
and directed sequencing approaches to genome sequence assembly of the 
rDNA impossible. As a result, the rDNA clusters are one of the largest 
remaining components of the human genome with no representation in the 
Human Genome Project.  
 
The highly repetitive nature of these clustered genomic repeats also prevents the 
application of commonly used techniques to investigate genomic instability such 
as array-based comparative genome hybridization (aCGH), single nucleotide 
polymorphism (SNP) analysis, and high-throughput paired-end sequencing 
approaches. Nevertheless, the very considerations that make the rDNA clusters 
difficult to study by conventional means also make them biologically interesting 
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from a genomic stability perspective. The sequence conservation, repeat length 
and high relative local concentration of the repeats involving multiple 
chromosomal loci are, in principle, conducive to cluster restructuring by 
homologous recombination. We previously physically characterized human rDNA 
cluster lengths, finding an average of 600 repeats per diploid genome spread 
over the 10 rDNA clusters, subject to wide person-to-person variability driven by 
strong meiotic recombination. The number of gene repeats per cluster changes 
with a frequency of approximately 10% per cluster per meiosis (3). The high 
meiotic recombination frequency phenotype of the rDNA led us to consider 
whether the rDNA clusters could serve as sentinel biomarkers for dysregulated 
mitotic recombination in cancer. 
 
Dysregulated recombination has the potential to mediate genomic restructuring in 
cancer (reviewed in (4)). We recently demonstrated that changes in rDNA cluster 
lengths in cultured mitotic human cells are a potential indicator of recombination-
mediated genomic destabilization by showing a 10-fold or 100-fold increase in 
the frequency of spontaneous rDNA cluster restructuring in cells deficient for the 
ataxia-telangiectasia mutated (ATM) protein or the Bloom syndrome (BLM) 
protein respectively (5), in line with the increased prevalence of malignancy in 
ATM (6) and BLM (7) patients. In order to determine whether the rDNA clusters 
are restructured in sporadic cancers generally, as well as in cancer 
predisposition syndromes like ATM and Bloom syndrome, we prospectively 
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recruited lung cancer, colorectal cancer, and pediatric leukemia patients for 
molecular analysis of their disease. 
 
Lung and colorectal cancers are the leading and second leading cause of 
American deaths from cancer, accounting for 28% and 9% of all cancer deaths 
respectively (8). Notably, both lung and colorectal cancers derive from tissues 
with potentially substantial exposure to environmental genotoxic agents. Many 
potential environmental carcinogens, including specifically those in tobacco 
smoke, are potent inducers of sister chromatid exchange (9-11), which is thought 
occur by a recombination-based mechanism (12). Ordinarily, mammalian 
cells efficiently suppress recombination-mediated genomic rearrangements (13, 
14), but damage or loss of this control of recombination, combined with 
protracted recombination induction by environmental agents, may significantly 
impact the etiology of tumors in these organs. Evidence suggesting potential 
cancer etiology relevance for dysregulated recombination, particularly in the case 
of lung cancer, includes both the overexpression of recombination genes (15) 
and ATM defects commonly found in this tissue (16). Conversely, pediatric 
leukemia is thought to driven by specific chromosomal events, rather than the 
gradual accumulation of malignant features caused by many years accumulating 
molecular genomic insults (17). This work reports the result of testing the 
hypothesis that dysregulated recombination is a significant feature of primarily 
sporadic adult lung and colorectal cancers rather than pediatric leukemias. 
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CHAPTER TWO 
 
 
Materials and Methods 
 
Human investigations were performed after approval by the University of 
Kentucky Institutional Review Board and Markey Cancer Center Protocol Review 
Committee and in accordance with an assurance filed with and approved by the 
Department of Health and Human Services. Informed consent was obtained from 
patients at the University of Kentucky Medical Center undergoing surgical 
resection for either lung or colorectal cancer, or from the parents of 
pediatric patients being treated for leukemia. For patients with solid tumors, 
peripheral blood was drawn prior to surgery. After surgery, resected specimens 
were examined by the Division of Surgical Pathology and pieces of both tumor 
and surrounding non-tumor tissue were removed for analysis. Leukemia patients 
had either peripheral blood or bone marrow aspirates removed for analysis 
periodically throughout the course of their treatment. All patient samples 
are referred to in this work by study code names. 
 
Sample processing: 
Solid tissues were rinsed on ice in RPMI 1640 medium containing antibiotics and 
10% fetal bovine serum (RPMI1640/FBS). Tissues were then disaggregated to 
single cells mechanically, either by gentle scraping and mincing, or by mincing in 
RPMI 1640/FBS and processing in a 50 µl pore size Medicon unit in a 
MediMachine, followed by debris removal by filtration with a 70 µl pore size 
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Filcon (all from Becton-Dickinson). For whole blood and bone marrow aspirates, 
leukocytes were isolated by ammonium chloride lysis. No digestive enzymes 
were used in the preparation of any of the single cell suspensions.  DNA-
containing cells were quantified by vital staining with 2 µg/ml acridine 
orange, followed by flow cytometric analysis with a 488 nm argon-ion laser 
triggering acquisition on green fluorescence (DNA content) essentially as 
described (18). Single cell suspensions were adjusted to 1 x 107 cells / ml final 
concentration in 0.8% low melting temperature agarose and allowed to solidify. 
High molecular weight genomic DNA was prepared from this solid phase cell 
suspension by treatment with 1% sarkosyl / 500 mM EDTA / 0.5 mg/ml 
proteinase K at 50 C for at least 16 hours, followed by treatment with 
phenylmethylsulfonyl fluoride (PMSF), extensive rinsing, and final equilibration in 
50% glycerol/ 10 mM Tris / 1 mM EDTA pH 8.0 and long-term storage at -20 C. 
 
Southern blot analysis: 
The rDNA clusters were analyzed by pulsed-field gel electrophoresis and 
Southern blotting as described (3). Approximately 1 µg genomic DNA in a 10 
µl solid-phase agarose slice was equilibrated with appropriate restriction 
digestion buffer and digested by EcoRV (New England Biolabs) to liberate intact 
rDNA clusters from bulk genomic DNA. Agarose slices containing 
digested genomic DNA were sealed into the wells of a 1% Pulse Field Certified 
agarose (Bio-Rad) gel in 44.5 mM Tris / 44.5 mM boric acid / 1.0 mM EDTA pH 
8.0 (0.5x TBE) and run using  a CHEF-MAPPER (Bio-Rad) in 0.5X TBE for 24 
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hours at 6 V/cm field strength, switching between 120° separated field vectors 
with a frequency ranging from 3 s to 90 s using a “ramp factor” of 0.357 (Bio-
Rad) at a constant temperature of 14 C to achieve approximately linear 
size resolution of between 30 kb and 1 Mb.  
 
Following electrophoresis, gels were equilibrated to 0.5% final concentration 
glycerol and dried at 65 C. Dried gels were rehydrated with water, denatured with 
0.4 N NaOH / 0.8 M NaCl, neutralized with 0.5 M Tris pH 8.0 / 0.8 M NaCl and 
prehybridized at 65 C in 2X SSC (300 mM NaCl / 30 mM Na-citrate) with 7% 
SDS and 0.5% casein. Gels were probed overnight at 65 C in fresh 
prehybridization solution using the rDNA-specific radiolabeled PCR products of 
primers 5'-GGGCTCGAGATTTGGGACGTCAGCTTCTG and 5'- 
GGGTCTAGAGTGCTCCCTTCCTCTGTGAG, amplified from pBSrDNA11, a 
pBluescript-based (Stratagene) plasmid containing a subcloned and sequenced 
segment of the human rDNA intergenic spacer generated by using the 
aforementioned primers to amplify human genomic DNA (3). Gels were rinsed at 
65 C with 2X SSC / 0.1% SDS followed by 0.5 X SSC / 0.1% 
SDS, briefly equilibrated with 2X SSC and developed by exposing a 
PhosphorImager cassette with subsequent imaging in a PhosphorImager 
(Molecular Dynamics). Raw data was obtained in TIFF format and processed 
using Adobe Photoshop. All images were processed en bloc. In 
no case did image processing either obscure bands from the raw data, or cause 
bands not apparent in the raw data to appear. 
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CHAPTER THREE 
 
 
Results 
We assay for dysregulated recombination in the rDNA by examining changes in 
the physical length of individual rDNA clusters (Figure 1). Every person has a 
unique configuration of these rDNA clusters (3), so the cluster lengths vary from 
person to person. Where possible, we compare the rDNA cluster lengths found in 
surgically excised nearby non-tumor tissue to the gene cluster lengths found in 
the tumor itself, and to gene cluster lengths from the patients’ peripheral blood as 
an additional control, indicated in the figure as the ‘N’, ‘T’ and ‘B’ lanes 
respectively. Our prior experiences with both human blood and cell lines 
indicated that analysis of gene cluster lengths from 50 kb to approximately 1 Mb 
is the most informative range for detection recombination-mediated alterations (3, 
5), so this is the methodology we followed in this present work. Gene clusters 
larger than 1 Mb all run together unresolved at the top of the gel in the region 
indicated by the star under these electrophoretic conditions. Otherwise, all 
unique gene clusters shorter than 1 Mb are resolved as individual bands. If the 
rDNA clusters are stable under mitotic cellular expansion, the banding pattern 
found in tumor cells will match that found in non-tumor cells (Figure 1 – ‘Stable’). 
Occasionally we observe a relatively low molecular weight ladder of bands at the 
bottom of the gel in tumor and normal tissues (Figure 1 – ‘Sample Fragility’) 
consistent with the 43 kb rDNA individual gene repeat length. These bands 
appear to arise from stochastic, low-frequency fragile-site breakage in individual 
rDNA repeats during the genomic DNA isolation procedure itself, rather than from 
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bona fide chromosomal alterations in cells; since the intensities of these bands 
follows a smooth Gaussian distribution and is not dependent upon liberation of 
the gene clusters from bulk genomic DNA by restriction enzyme digestion. 
Although this fragility may contribute to initiating chromosomal alterations in gene 
cluster lengths, we do not consider a low molecular weight banding pattern on its 
own to be indicative of genomic instability. 
 
On the other hand, if a tumor has lost control over recombination, the 
configuration of gene cluster lengths in the tumor will be different relative to non-
tumor cells (5). If the rDNA cluster length restructuring occurred before clonal 
expansion of the proto-tumor cell, for example in the lungs of a heavy smoker, 
the altered length gene clusters will be present in the entirety of the subsequent 
tumor. In this case, some bands found in non-tumor tissue may be lost in the 
tumor, and new bands become evident (Figure 1 – ‘Instability Before 
Expansion’). These new bands are indicated in the figure by filled triangles and 
show intensities proportional to their length. Tumor samples are commonly 
contaminated with non-tumor tissue, so fainter bands in the tumor sample 
occurring at the same position as bands found in normal tissue likely 
represent contaminating normal tissue rather than heterogeneity of cluster 
lengths within the tumor itself.  
 
Finally, gene cluster lengths may have changed both before clonal expansion of 
the proto-tumor cell and also during the clonal expansion of the new tumor. 
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Alterations that occurred after the tumor began clonal expansion will manifest as 
new bands, but with reduced intensity (Figure 1 – ‘Ongoing Instability’) shown by 
open triangles. The degree to which the intensity of these “minor bands” is 
reduced relative to the intensities of the “major new bands” in the tumor is 
determined by the fraction of the tumor made up of cells with these alterations.  
The later in the clonal expansion the gene cluster alteration occurred, the fainter 
the minor intensity bands will be. In contrast to the ‘Sample Fragility’ bands, new 
minor bands in the tumor occur at high molecular weights, do not vary smoothly 
in intensity, and are dependent upon liberation from bulk genomic DNA by 
restriction digestion prior to visualization on the gels. 
 
We first analyzed lung squamous cell carcinoma (Figure 2). Four out of eleven 
patients, TIBBO-JU, PANIU-HA, AFILA-PA and JIMIL-GE show no differences 
between observed gene cluster lengths in tumor relative to non-tumor tissues, 
indicating rDNA cluster stability. Two more patients, RESCA-BO and OFIAT-MA, 
show the same gene cluster profiles between tumor and non-tumor cells, with the 
exception of an even laddering of bands in the lower part of the gel (indicated by 
round dots) consistent with fragility in the isolated genomic DNA. We therefore 
also consider these tumors to be gene cluster stable. The stability of TIBBO-JU is 
particularly remarkable since this tumor was a recurrence following both 
chemotherapy and radiation treatment. Clearly the intense genomic damage from 
treatment does not necessarily cause loss of gene cluster stability, nor is loss of 
gene cluster stability necessarily required for poor response to therapy. 
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The remaining five lung squamous cell carcinomas all show evidence of 
structural alteration in the rDNA. XEPRY-DA, QIPPI-SH and VEKOR-CH show 
bands found in tumor cells that are not present in either blood or surrounding 
non-tumor cells (Figure 2, solid triangles). In XEPRY-DA and VEKOR-CH, novel 
bands are each approximately 30% the intensity of the bands found in non-tumor 
tissue, consistent with the rearrangements occurring early in the 
clonal expansion of the initial proto-tumor cell, or in the pre-tumor lung tissue 
prior to the initiation of clonal expansion,  in which case the tumor would make up 
30% of the cells in the tumor sample, with the remaining 70% being normal 
tissue. The novel bands in QIPPI-SH are on the order of intensity of bands in 
non-tumor tissue, suggesting these genomic alterations preceded clonal tumor 
cell expansion. 
 
Finally, two of the poorly differentiated lung squamous cell carcinomas, BONTA-
DA and WOFUT-BR, show evidence of extensive and ongoing recombinational 
instability. In both cases, there are new major bands in the tumors not found in 
non-tumor tissue (Figure 2, solid triangles). Significantly, there are also several 
high molecular weight minor intensity bands (Figure 2, unfilled triangles). The 
presence of both new major and minor intensity bands indicates that not only 
were the rDNA clusters altered in the pre-tumor tissue, as might be expected for 
cells under genotoxic pressure from tobacco exposure, but that these gene 
clusters continued to structurally rearrange in the early history of the tumor after 
the prototumor cells had already become committed to clonal expansion. 
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We see a similar level of gene cluster restructuring in lung adenocarcinomas 
(Figure 3). In six of 14 cases, there is no evidence for rDNA cluster 
rearrangement. In PHAZL-SA, SEBON-CL, and IBINA-KE gene cluster lengths in 
all of non-tumor, tumor and blood samples are longer than the approximately 1 
Mb resolution limit of the gels. This absence of resolved size differences in the 
gene clusters from the tumor samples compared to the non-tumor controls 
indicates that these tumors did not undergo recombination-mediated gene cluster 
alterations, although we cannot preclude alterations in the unresolved gene 
cluster lengths larger than 1 Mb in these patients. The banding patterns in 
MILST-BR, PARLA-CA and CEVAT-MA are also the same between tumor and 
either peripheral blood or normal lung, indicating gene cluster stability. However, 
UGOBI-FO, KABIG-NI and EVIEN-RA show evidence of pre-tumor alteration with 
new major bands, but no new minor banding. The remaining five tumors, 
TIPOR-PA, GLOAK-EU, MEERY-BE, MUVID-DO and FOBIK-TE all show both 
new major and minor intensity bands, consistent with a period of dysregulated 
recombination both before and immediately following commitment to clonal tumor 
cell expansion. 
 
The colorectal tumor patients show a similar distribution of rDNA cluster 
instability as the lung cancer patients. Of the ten colon cancer samples (Figure 
4), four appear stable (SAGOF-GR, FONET-VI, ARPIC-RO and EBETH-DA), and 
five more show pre-clonal expansion alterations (VOBLE-JO, DAPEB-MA, 
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COBEZ-WI, RIZON-HE and SNARG-GE), while one shows both new major and 
minor bands indicative of gene cluster restructuring both before and after 
tumor-cell commitment (PULAB-GE). The process of metastasis does not 
necessarily involve recombinational gene cluster restructuring, as seen in the 
colon tumor from EBETH-DA which was surgically recovered from a colon 
metastasis to lung. Likewise, it is notable that unlike the lung cancer patients, 
nearly all of whom have a smoking history, rDNA cluster alterations are 
also seen in colon cancer patient tumors from either non-smokers (RIZON-HE, 
PULAB-GE) or individuals with a relatively modest smoking history (VOBLE-JO). 
 
The rectal cancers follow a similar pattern (Figure 5). Two of four patients 
(CLIMP-HA and DOOVA-CL) show light stochastic breakage but are otherwise 
gene cluster stable. Two other patient tumors show evidence of either pre-
expansion (BINTA-CH) or pre- and post-clonal expansion (WIVIT-HE) gene 
cluster instability. Our experience was that non-tumor rectal tissue was difficult to 
work with, so generally we compared tumor gene cluster structure to that 
from peripheral blood. 
 
Architectural rearrangements in the rDNA clusters are less frequent in the 12 
pediatric leukemias we have examined (Figure 6). Comparing peripheral blood 
containing blasts before or shortly after the initiation of treatment to peripheral 
blood from the same patients in remission with no residual detectable blasts after 
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recovery from induction chemotherapy shows the same pattern of bands in 10 of 
the 12 different pediatric patients. Evidence of preexpansion 
rearrangement is detected in NIPRY-JA and RAMAH-LE, with novel band 
intensities proportional to the fraction of blasts found in these patients’ peripheral 
blood. 
 
PALT-BR is an interesting, if tragic, case. We first encountered this 5-year old 
boy in remission (R) three years after a diagnosis of and treatment for pre-B cell 
acute lymphocytic leukemia prior to his allogeneic stem cell transplant. After his 
transplant, his peripheral blood shows the rDNA cluster pattern of the engrafted 
donor marrow (D). Shortly after the transplant, the patient relapsed, and we see a 
re-establishment of his pre-transplant rDNA cluster pattern (L) two weeks prior to 
his death. Even though this individual underwent years of intensive 
chemotherapy and full body irradiation, his disease shows no evidence of rDNA 
cluster instability (R vs. L, ignoring the bands from the donor marrow). 
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Figure 3.1: Gene Cluster Instability Phenotypes 
 
 
 
Patterns of genomic instability in the rDNA. In each case lanes are ‘N’ – non-tumor 
tissue, ‘T’ – tumor tissue, ‘B’ – peripheral blood. The grouped bands at the star represent 
unresolved gene clusters larger than 1 Mb. The lower limit of resolution of the gel is 50 
kb. Breakage from fragile DNA not involving actual chromosomal restructuring is 
indicated by dots. New bands found in tumors and not in non-tumor tissue are indicated 
by solid triangles. New bands found in a fraction of tumor tissue but not non-tumor tissue 
are indicated by open triangles. Bands found in non-tumor tissue but under-represented 
in tumor tissue are indicated by arrows.  
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Figure 3.2: Lung Squamous Cell Carcinoma 
 
 
 
 
 
Lung squamous cell carcinoma rDNA stability analysis. rDNA clusters resolved up 
to 1 Mb in length (star). ‘N’ – non-tumor tissue; ‘T’ – tumor tissue; ‘B’ – peripheral blood. 
Sample fragility indicated by dots, new major bands found in tumors indicated by solid 
triangles, new minor bands found in tumors indicated by open triangles. Coded patient 
names are indicated below each gel. Differentiation status of tumors: ‘mod’ is moderately 
differentiated, ‘mod/poor’ is moderately to poorly differentiated, ‘poor’ is poorly 
differentiated.Any clinical pretreatment is indicated as ‘chemo/XRT’ – chemotherapy and 
radiation therapy. Pathological staging of tumors is indicated. Smoking history is given in 
‘ppy’ – person-packyears, or ‘yes’ when the patient is a smoker but smoking history has 
not been obtained, ‘unk’:unknown.  
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Figure 3.3: Lung Adenocarcinoma 
 
 
 
 
 
Lung adenocarcinoma rDNA stability analysis. rDNA clusters resolved up to 1 Mb 
in length (star). ‘N’ – non-tumor tissue; ‘T’ – tumor tissue; ‘B’ – peripheral blood. Sample 
fragility indicated by dots, new major bands found in tumors indicated by solid triangles, 
new minor bands found in tumors indicated by open triangles. Coded patient names are 
indicated below each gel. Differentiation status of tumors: ‘mod’ is moderately 
differentiated, ‘mod/poor’ is moderately to poorly differentiated, ‘poor’ is poorly 
differentiated. Pathological staging of tumors is indicated. Smoking history is given in 
‘ppy’ – person-pack-years, or ‘yes’ when thepatient is a smoker but smoking history has 
not been obtained, ‘unk’: unknown.  
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Figure 3.4: Colon Adenocarcinoma 
 
 
Colon adenocarcinoma rDNA stability analysis. rDNA clusters resolved up to 1 Mb 
in length (star). ‘N’ – non-tumor tissue; ‘T’ – tumor tissue; ‘B’ – peripheral blood. Sample 
fragility indicated by dots, new major bands found in tumors indicated by solid triangles, 
new minor bands found in tumors indicated by open triangles. Coded patient names are 
indicated below each gel. Differentiation status of tumors: ‘well’ is well differentiated, 
‘mod’ is moderately differentiated, ‘mod/poor’ is moderate to poorly differentiated, 
alternatively tumors are classified as either mucinous or metastatic. Pathological staging 
of non-metastatic tumors is indicated. ‘from lung’ indicates likely metastatic colon 
adenocarcinoma surgically excised from lung tissue. Smoking history is given in ‘ppy’ – 
person-pack-years, or ‘yes’ when the patient is a smoker but smoking history has not 
been obtained, or ‘no’ for a non-smoker, ‘unk’: unknown.  
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Figure 3.5 Rectal Adenocarcinoma 
 
 
 
Rectal adenocarcinoma rDNA stability analysis. rDNA clusters resolved up to 1 Mb 
in length (star). ‘N’ – non-tumor tissue; ‘T’ – tumor tissue; ‘B’ – peripheral blood. Sample 
fragility indicated by dots, new major bands found in tumors indicated by solid triangles, 
new minor bands found in tumors indicated by open triangles. Coded patient names are 
indicated below each gel. Differentiation status of tumors: ‘mod’ is moderately 
differentiated. Pathological staging of non-metastatic tumors is indicated. Smoking 
history is given in ‘ppy’ – person-pack-years, or ‘no’ for a non-smoker. 
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Figure 3.6: Pediatric Leukemia 
 
 
 
 
Pediatric leukemia rDNA stability analysis. rDNA clusters resolved up to 1 Mb in 
length (star). ‘L’ – leukemia: peripheral blood containing blasts; ‘R’ – remission: 
peripheral blood post-treatment with no detectable blasts; ‘D’ – donor: peripheral blood 
following engraftment of transplanted bone marrow from an allogeneic donor. Coded 
patient names are indicated below each gel. The percentage of blasts in leukemia 
samples is indicated. Leukemic classification: ‘pre-B ALL’ – pre-B cell acute lymphocytic 
leukemia, ‘mono AML’ – monocytic acute myelogenous leukemia, ‘T-cell ALL’ – T-cell 
acute lymphocytic leukemia.  
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CHAPTER FOUR 
 
Discussion 
Of the solid tumors analyzed for rDNA cluster instability, the overall frequency of 
any observed rDNA cluster alteration is 54% (21 of 39: 95% confidence interval 
39% to 68% by adjusted Wald method). 31% (12 of 39) demonstrated alterations 
consistent with pre-clonal expansion alterations only, and a further 23% (9 of 39) 
showed evidence of recombination-mediated rDNA cluster alterations both 
before the start of clonal tumor expansion, as well as in the several rounds of cell 
division immediately following commitment to clonal expansion. No evidence of 
rDNA cluster instability was observed in 46% (18 of 39) of cases. Since the rDNA 
clusters range in size up to 6 Mb and we only analyzed clusters smaller than 1 
Mb, the frequency of 54% observed gene cluster alterations is likely an 
underestimate.  
 
Considering that the rDNA clusters only make up approximately 0.5% of the 
diploid human genome, this alteration frequency of over 50% in human solid 
tumors indicates that the rDNA clusters are extraordinarily sensitive indicators of 
the capacity for human cancer to use recombination to alter sub-microscopic 
genomic structure, and that this sub-microscopic genomic restructuring is one of 
the most frequent chromosomal aberrations found in nonhereditary 
solid tumors. In comparison, rDNA alteration in pediatric leukemia is only found in 
approximately 15% of cases. This frequency difference in cluster recombinational 
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restructuring between pediatric leukemia and adult solid tumors (P=0.04 Fisher’s 
two-tailed exact test) may reflect the adult tumors’ progressive accumulation of 
genomic insults from both time and genotoxic environmental exposure, 
compared to more simple specific translocation driven disease in the pediatric 
patients. 
 
The rDNA clusters are critical components of cellular metabolism, so 
recombinational dysregulation in the rDNA may directly alter the capacity for 
tumor cell growth. The hypermetabolic nature of cancer cells requires expanded 
capacity for protein synthesis. Since rRNA production is rate limiting for the 
construction of new ribosomes, instability in the rDNA clusters will allow for 
positive selection of sub-populations of cancer cells that have expanded 
their rDNA complement. Upregulation of rDNA expression through epigenetic 
derepression is already known in lung cancer (19), making selectable gene 
amplification of the rDNA an additional effective mechanism for producing the 
large number of required ribosomes in hypermetabolic, relatively rapidly dividing 
tumor cells. 
 
In addition to their direct contribution to tumor cell metabolism, instability of the 
rDNA may be indicative of broader recombination-based genomic instability in 
repetitive genomic elements and serve as sentinel biomarkers for genomic 
alteration mediated by recombination between other high-similarity low-copy 
repeated sequences (20). For example, dysregulated recombination causing 
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genomic restructuring of centromeric α-satellite repeats may result in centromeric 
dysfunction, contributing to the aneuploidy commonly seen in adult solid tumors 
(21). Intriguingly, other highly self-similar clustered gene loci in the human 
genome (22) express protein products found with relative specificity only in 
cancer and in highly recombination-active tissues such as testes: the so-called 
“CT” genes (23). We are actively pursuing whether these loci are also 
recombinationally destabilized in cancer and with what potential clinical 
relevance. 
 
From a predictive standpoint, since DNA double-strand breaks are potent 
inducers of homologous recombination in human cells (24), and many 
chemotherapeutic agents exert their genotoxic effects through DNA double-
strand breaks, the use of these agents in tumors with dysregulated 
recombination may prove to be problematic. Dysregulated recombination in 
tumor cells may facilitate large-scale genomic restructuring in response to 
radiomimetic chemotherapy accelerating establishment of chemotherapeutic 
resistance. Similarly, exposure to genotoxic agents from tobacco in potentially 
numerous pre-cancerous cells with dysregulated recombination may contribute to 
the synchronous dissimilar primary lung tumors sometimes found in heavy 
smokers. 
 
We are continuing to follow and expand our enrolled patient population to 
ascertain whether assaying rDNA restructuring in tumor cells has prognostic 
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and/or predictive value. Specifically, now that we can divide solid tumor cancer 
patients into two approximately evenly populated cohorts based on whether 
tumors either do or do not display evidence of dysregulated recombination, we 
will determine whether dysregulated recombination is informative with 
regard to risk of tumor recurrence, the disease-free survival interval post-surgery 
and with overall survival. For patients that undergo adjuvant chemotherapy or 
radiation therapy postsurgery, we will also determine whether the degree of 
responsiveness to adjuvant therapy is influenced by the presence of 
dysregulated recombination in the primary tumors. The dysregulated 
recombination cohort can be further subdivided, based on the presence or 
absence of minor banding in the tumor sample, into patients for whom the tumor 
was still actively recombining the rDNA clusters during the initial phase of tumor 
clonal expansion and those for whom dysregulated recombination appeared to 
be restricted to the interval before primary tumor clonal expansion, allowing 
further fine-tuning of the potential clinical application of the assay. 
 
In summary, we have detected structural alterations to the ribosomal RNA gene 
clusters in over 50% of the adult solid tumors examined, making these genomic 
rearrangements one of the most common specific chromosomal alterations in 
adult solid tumors. The functional significance of the rDNA for the capacity of 
tumor cells to produce protein as well as the potential sentinel biomarker nature 
of the rDNA for recombination-driven genomic alterations involving other highly 
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conserved low copy repetitive genomic elements suggests assaying rDNA cluster 
instability in tumors may prove to have prognostic and/or predictive value. 
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